Nat-Gefitinib 250 mg

Gefitinib 250 mg tablets are an oral medication used to manage certain types of cancer. This targeted therapy works by inhibiting specific proteins to slow tumor growth.

Gefitinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic markers. It targets epidermal growth factor receptor (EGFR) mutations, which can drive cancer cell proliferation. Patients often wonder, 'What is gefitinib used for?' This medication is designed to interfere with the growth and spread of cancer cells, offering a targeted approach to cancer therapy.

Common effects of gefitinib may include skin rash, diarrhea, and fatigue. Some users also report appetite loss and dry skin. These effects can vary widely among individuals, and it's important to monitor any changes while using this medication.

Gefitinib should be handled with care, especially for those with pre-existing lung conditions. Regular medical supervision is advised to monitor for potential side effects. It's crucial to follow the guidance of a healthcare provider when using this medication.

Gefitinib may interact with certain medications, including those metabolized by the liver's CYP3A4 enzyme. It's important to inform healthcare providers about all current medications to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect the metabolism of gefitinib.